MRT-2359
Monte Rosa Therapeutics
['monte rosa']
monte rosa therapeutics presents preclinical data from gspt1 degrader program focused on myc-driven cancers at aacr 2023 #stocksoftheday #stockalert #stocknews #cancer #newclinicaltrialdata 
Find the most important news and press releases about U.S. publicly-traded companies in real-time and stay ahead of the game!